当前位置:首页 - 行情中心 - 泓博医药(301230) - 财务分析 - 现金流量表

泓博医药

(301230)

  

流通市值:55.68亿  总市值:61.90亿
流通股本:1.63亿   总股本:1.81亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金503,296,300.14316,131,629.31154,412,808.38554,924,593.35
  收到的税费返还3,351,538.951,718,091.97409,896.583,489,204.54
  收到其他与经营活动有关的现金31,242,093.3828,276,182.5221,709,640.546,457,583.53
  经营活动现金流入小计537,889,932.47346,125,903.8176,532,345.46604,871,381.42
  购买商品、接受劳务支付的现金143,038,527.6893,083,374.9842,920,916.56172,243,284.85
  支付给职工以及为职工支付的现金222,750,637.61145,009,068.8375,662,585.84251,268,300.46
  支付的各项税费7,899,858.777,000,073.662,704,255.0212,495,888.21
  支付其他与经营活动有关的现金66,241,324.8429,018,576.9625,497,112.6833,351,965.77
  经营活动现金流出小计439,930,348.9274,111,094.43146,784,870.1469,359,439.29
  经营活动产生的现金流量净额97,959,583.5772,014,809.3729,747,475.36135,511,942.13
二、投资活动产生的现金流量:
  收回投资收到的现金395,857,843.34245,857,843.34160,818,302.3923,000,000
  取得投资收益收到的现金22,140,583.6111,715,583.616,807,055.73105,380.53
  处置固定资产、无形资产和其他长期资产收回的现金净额30,318270270121,442
  投资活动现金流入小计418,028,744.95257,573,696.95167,625,628.1223,226,822.53
  购建固定资产、无形资产和其他长期资产支付的现金66,090,973.6539,625,629.6117,318,035.7843,316,262.01
  投资支付的现金329,300,000222,800,000154,800,00023,300,000
  投资活动现金流出小计395,390,973.65262,425,629.61172,118,035.7866,616,262.01
  投资活动产生的现金流量净额22,637,771.3-4,851,932.66-4,492,407.66-43,389,439.48
三、筹资活动产生的现金流量:
  吸收投资收到的现金3,649,8003,649,800--
  取得借款收到的现金10,000,0005,750,000-25,664,755.58
  筹资活动现金流入平衡项目00-0
  筹资活动现金流入小计13,649,8009,399,800-25,664,755.58
  偿还债务支付的现金10,000,00010,000,000-25,664,755.58
  分配股利、利润或偿付利息支付的现金42,855,593.1115,219,312.812,287,869.1854,044,722.98
  支付其他与筹资活动有关的现金21,936,308.4314,709,413.967,520,375.3525,823,977.6
  筹资活动现金流出小计74,791,901.5439,928,726.7619,808,244.53105,533,456.16
  筹资活动产生的现金流量净额-61,142,101.54-30,528,926.76-19,808,244.53-79,868,700.58
四、汇率变动对现金及现金等价物的影响-4,983,315.54-2,973,470.67-1,553,587.611,815,915.65
五、现金及现金等价物净增加额54,471,937.7933,660,479.283,893,235.5614,069,717.72
  加:期初现金及现金等价物余额52,818,664.8952,818,664.8952,818,664.8938,748,947.17
  期末现金及现金等价物余额107,290,602.6886,479,144.1756,711,900.4552,818,664.89
补充资料:
  净利润-28,729,363.74-34,294,767.32
  资产减值准备-10,255,861.78-16,017,088.85
  固定资产和投资性房地产折旧-14,898,912.31-28,073,318.34
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-14,898,912.31-28,073,318.34
  无形资产摊销-282,148.7-502,802.06
  长期待摊费用摊销-22,151,892.38-42,971,430.92
  处置固定资产、无形资产和其他长期资产的损失----41,517.55
  固定资产报废损失-129,563.43-301,281.49
  公允价值变动损失--8,792,384.73--6,996,140.63
  财务费用-6,675,658.58-6,359,371.37
  投资损失--11,631,711.8--105,380.53
  递延所得税--2,495,746.3--15,539,703.94
  其中:递延所得税资产减少--3,620,694.56--16,388,888.96
    递延所得税负债增加-1,124,948.26-849,185.02
  存货的减少--11,546,029.6--16,890,222.3
  经营性应收项目的减少-11,233,942.39--16,791,347.52
  经营性应付项目的增加--2,481,678.04-34,331,004.08
  其他-3,430,284.04-6,116,980.22
  现金的期末余额-86,479,144.17-52,818,664.89
  减:现金的期初余额-52,818,664.89-38,748,947.17
  现金及现金等价物的净增加额-33,660,479.28-14,069,717.72
公告日期2026-10-232026-08-282026-04-292026-04-29
审计意见(境内)标准无保留意见
TOP↑